Benchling is a leading life sciences R&D cloud platform that helps biotech and pharmaceutical companies accelerate research and development. The platform combines laboratory information management systems (LIMS), electronic lab notebooks (ELN), and registry capabilities with workflow automation and data analytics. Founded by former MIT and Stanford researchers, Benchling serves hundreds of organizations from startups to large pharma companies, enabling them to design, test, and manufacture everything from life-saving medicines to sustainable materials more efficiently.
Benchling has received investment from 2 venture capital firms.
Cloud-based life sciences R&D platform providing laboratory information management and data analysis tools for biotech and pharma companies.
Benchling has received investment from Andreessen Horowitz Bio + Health, Anthem Venture Partners. These venture capital firms and investors provide both capital and strategic support.
Benchling has raised $625M in total funding. The company operates in the Biotech sector.
Benchling was founded in 2012 and is headquartered in San Francisco, California.
Benchling operates in the Biotech sector. Cloud-based life sciences R&D platform providing laboratory information management and data analysis tools for biotech and pharma companies.
